Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ntaliarda, I. Lilis (ioannislilis@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), V. Papaleonidopoulos (papaleonv@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), I. Giopanou (giopanou@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Oplopoiou (moplopoiou@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Lianou (pha2306@upnet.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), G. A Giotopoulou (giotopoulou.g@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), A. Marazioti (amarazioti@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Spella (magsp@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), S. Marwitz (smarwitz@fz-borstel.de / Clinical and Experimental Pathology, R. Center Borstel; Airway Research Center North (ARCN); Member of the German Center for Lung Research (DZL),Borstel), T. Goldmann (tgoldmann@fz-borstel.de / Clinical and Experimental Pathology, R. Center Borstel; Airway Research Center North (ARCN); Member of the German Center for Lung Research (DZL),Borstel), V. Bravou (vibra@upatras.gr / Department of Anatomy-Histology-Embryology, F. of Medicine; University of Patras,Rio), G. T. Stathopoulos (gstathop@upatras.gr / Department of Anatomy-Histology-Embryology, F. of Medicine; University of Patras,Rio). LSC - 2018 - A requirement for mast cells in lung adenocarcinoma. 5375

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Macrophages in lung adenocarcinoma Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 LSC - 2019 - STAT-3 is activated in COPD airway epithelial cells. Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 LSC - 2021 - Regulation of PA200 in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 LSC - 2021 - Preclinical evaluation of IL-1ß inhibition against KRAS-mutant lung adenocarcinoma Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 LSC - 2017 - Tumor-associated macrophages promote inflammasome-dependent lung tumor progression in mice Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 LSC - 2019 - Neutrophil-derived microvesicles are internalised by lung epithelial cells and induce inflammatory activation Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival Source: Eur Respir J 2009; 33: 118-126 Year: 2009 LSC - 2017 - Exosomal miRNA cargo in non small-cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021